IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.
Kasamatsu T, Hashimoto N, Sakaya N, Awata-Shiraiwa M, Ishihara R, Murakami Y, Masuda Y, Gotoh N, Nagai K, Oda T, Yokohama A, Saitoh T, Handa H, Tsukamoto N, Hayashi K, Murakami H.
Kasamatsu T, et al.
Clin Exp Med. 2021 May;21(2):323-329. doi: 10.1007/s10238-020-00681-w. Epub 2021 Mar 12.
Clin Exp Med. 2021.
PMID: 33709342